Shin Nippon Biomedical Laboratories, Ltd. (2395) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Shin Nippon Biomedical Laboratories, Ltd. (2395) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Shin Nippon Biomedical Laboratories, Ltd. (2395) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Shin Nippon Biomedical Laboratories, Ltd. (2395) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
37 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a healthcare service provider that provides drug and clinical development service to biopharmaceutical companies. Its preclinical services include SNBL USA preclinical expertise, SNBL preclinical drug safety research (DSR) expertise, general toxicology, immunotoxicology and specific toxicology. SNBL also provides developmental and reproductive toxicology, carcinogenicity testing, pharmacokinetics and biodistribution, safety and efficacy models, acute radiation syndrome (ARS), safety pharmacology, blood and tissue services, and archiving among others. SNBL also conducts research and development activities.

Shin Nippon Biomedical Laboratories, Ltd. (2395) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped

  
Source:
Document ID
GDPH138989D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Shin Nippon Biomedical Laboratories, Ltd., Medical Devices Deals, 2010 to YTD 201691
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare, Deal Details1221
  Venture Financing121
    WaVe Life Sciences Raises USD18 Million in Series A Financing121
  Partnerships131
    Shin Nippon Biomedical Labs Terminates Licensing Agreement with Besins Healthcare131
    SNBL USA Enters into Contract with BARDA141
    Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical151
    Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical161
    ISA Therapeutics Enters into R&D Agreement with Shin Nippon Biomedical Labs171
    Shin Nippon Biomedical Labs Enters Into Research Agreement With Nagasaki University181
    Shin Nippon Biomedical Labs Enters Into Co-Development Agreement With Nihon University191
    Shin Nippon Biomedical Labs Enters Into Co-Development Agreement With Retina Institute Japan201
    Shin Nippon Biomedical Labs Enters Into Research Agreement With Riken211
    Shin Nippon Biomedical Labs To Enter Co-Development Agreement With Chiome Bioscience221
    Shin Nippon Biomedical Labs Enters Into Research Agreement With Nagasaki University For Cerebral Infarction Treatment232
    Shin Nippon Biomedical Labs Enters Into Research Agreement With Center For iPS Cells Research And Application251
  Licensing Agreements261
    Transcept Pharma And Shin Nippon Biomedical Labs Enter Into Licensing Agreement For Acute Migraine Treatment262
    Shin Nippon Biomedical Labs Enters Into Licensing Agreement With Pastorus Pharma281
  Equity Offering291
    Shin Nippon Biomedical Labs Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants291
    Shin Nippon Biomedical Labs Completes Private Placement Of Shares For US$35.5 Million Upon Exercise Of Warrants301
    Shin Nippon Biomedical Labs Completes Private Placement Of Shares For US$38 Million Upon Exercise Of Warrants311
    Retina Institute Japan Announces Private Placement Of 300 Million Shares321
Shin Nippon Biomedical Laboratories, Ltd. - Key Competitors331
Key Employees341
Locations And Subsidiaries352
  Head Office351
  Other Locations &Subsidiaries352
Appendix371
  Methodology371
  About GlobalData371
  Contact Us371
  Disclaimer371

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Shin Nippon Biomedical Laboratories, Ltd. (2395) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Shin-Nippon-Biomedical-Laboratories-Ltd-2395-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-21735>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Shin Nippon Biomedical Laboratories, Ltd. (2395) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Shin-Nippon-Biomedical-Laboratories-Ltd-2395-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-21735>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research